WJPPS Citation

Login

Search

News & Updation

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: New Impact Factor 2026
  • WJPPS Impact Factor has been Increased to 8.485 for Year 2026.

  • WJPPS: MAY ISSUE PUBLISHED
  • MAY 2026 Issue has been successfully launched on 1 MAY 2026.

Abstract

REVERSED-PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY (RP- HPLC) BASED ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR PHARMACEUTICAL DOSAGE FORMS: A COMPREHENSIVE REVIEW

Aman Jain*, Kamal Singh Rathore, Anju Goyal

ABSTRACT

High-performance liquid chromatography (HPLC) has long served as the central tool for checking the quality of pharmaceutical products. As drug formulations grow more complex— often combining multiple active ingredients or utilizing advanced delivery matrices—the industry requires highly reliable analytical techniques to ensure product safety and clinical efficacy. Reversed-phase HPLC (RP-HPLC) remains the preferred choice in most quality control laboratories because it delivers excellent peak resolution, handles a wide variety of compounds, and yields highly reproducible results. This review provides a detailed look at how RP-HPLC methods are developed and validated for modern dosage forms today. We break down the core physicochemical factors that drive separations, such as stationary phase chemistry, mobile phase selection, and the critical role of pH in controlling analyte ionization. Additionally, the paper discusses the industry's significant shift away from traditional trial-and- error testing toward Analytical Quality by Design (AQbD), a structured approach now heavily emphasized by the ICH Q14 guidelines. We also walk through the strict validation requirements set by ICH Q2(R2), explaining the practical importance of testing for specificity, forced degradation, linearity, accuracy, precision, and overall method robustness. Finally, the review explores recent technological upgrades from the past few years, including the rise of core-shell columns, two-dimensional liquid chromatography (2D-LC), and the push for greener analytical practices. By highlighting these trends alongside the potential future impact of artificial intelligence on method optimization, this paper serves as a practical blueprint for researchers looking to build and validate robust, regulatory-compliant RP-HPLC procedures.

Keywords: Reversed-Phase HPLC; Analytical Method Development; Method Validation; Pharmaceutical Dosage Forms; Stability-Indicating Methods; Analytical Quality by Design (AQbD); ICH Guidelines.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More